Introduction

Cerebral ischemia, or brain ischemia, is a condition that occurs when there isn’t enough blood supply to meet the metabolic demand of the brain. This results in limited oxygen supply in the brain, or cerebral hypoxia, which leads to the death of brain tissue, cerebral infarction, or an ischemic stroke. This condition is a sub-type of stroke, along with subarachnoid hemorrhage and intracerebral hemorrhage. There are two kinds of ischemia, focal ischemia, and global ischemia.

There are several risk factors involved in brain ischemia, and even other disease complications may lead to the ischemic condition. Heart problems are one among many, and according to the Centers for Disease Control and Prevention, it was estimated that strokes kill approximately 140,000 Americans each year, almost equal to 1 out of every 20 deaths. Each year, more than 795,000 people in the United States have a stroke, and approximately 610,000 of these are new stroke cases.

Report Coverage

This report by Mordor Intelligence provides extensive insights into the current scenario and growth prospects of the market studied. Detailed graphical representations of the pipeline landscape, based on various phases, and the status of clinical trials, across major regions of the world, are given, with data obtained from multiple sources. The report also comprises a list of key sponsors with pipeline products for the concerned market.

Brain Ischemia Clinical Trial Analysis by Phase and Status

• The clinical trial analysis for (disease name) indicates that there are around XX number of trials under various phases
• Phase X trials accounted for the majority share
• The trial data analysis suggests a number of ongoing trials, as well as ones that have been terminated

Brain Ischemia Clinical Trials Analysis, by Geography

• By geography, the scope of the report covers the regional assessment for clinical trials, globally. It covers concise information regarding registered clinical trials in different countries, across several developed and emerging markets
• The increasing number of brain ischemia cases and the rising number of accidents every year are a few driving factors in the market

Key Sponsors in Brain Ischemia Clinical Trials

The report will cover analysis on trails and information on key sponsors, companies, and researchers.

Research Methodology

Our data collection team builds scientific research models, based on data sourced from various internal databases, primary and secondary researches, and our in-house team of research experts. The pipeline assessment reports are generated based on information procured from various stakeholders, such as sponsors, clinical trial organizations, pharmaceutical companies, government bodies, trade agencies, industry journals, scientific literature databases, investor reports, press release statements, and several other sources. The data generated using secondary research and primary research is validated through discussions with industry KOL’s and C-suite executives. The data presented in the reports is continuously updated to incorporate the most relevant and authentic information to our clients.

Reasons to buy the Report

This report will help you to understand

• The number of clinical trials that are being conducted worldwide
• The key products under development (Phase I, Phase II, and Phase III)
• The main areas of research under development (by product, mechanism of action, molecule, delivery, etc.)
• The average recruitment size in trials
• Key deals between institutions and industries
• Insights on regional- and country-level data
• Dormant and discontinued studies across the category
• Information on key sponsors and profiles
• Protocol and design comparisons, to generate the best solution for your product development strategy